Identification of apoptosis-related microRNAs and their target genes in myocardial infarction post-transplantation with skeletal myoblasts
Open Access
- 19 August 2015
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 13 (1) , 270
Abstract
Skeletal myoblasts (SkMs) has provided a promising treatment for myocardial infarction (MI). Functioning as posttranscriptional regulators, microRNAs (miRNAs) play important roles in cardiac repairment and stem cell regulation. However, the correlation between miRNAs and their targeted genes in SkM cell therapy for MI was not fully understood. We explored the cardioprotection by SkMs in infracted rats and determined cardiac functions at 4 weeks. In addition, we compared the expression profiles of miRNAs and mRNAs in post-MI rats with or without SkM cell therapy using microarray. The concordance between miRNA expression and mRNA levels of potential target genes was confirmed by quantitative real-time PCR. Quantitative echocardiography and histology showed improved cardiac function, attenuated heart infarcted area and inhibited cardiomyocyte apoptosis in the SkM group, compared with MI group. We identified that 160 miRNAs were differentially expressed in MI group as compared to the control group and 78 miRNAs were differentially expressed in the SkM treated group as compared to the untreated post-MI. We focused on a novel set of apoptosis-associated miRNAs and their target genes, among which 4 miRNAs (miR-30a-5p, miR-30c-5p, miR-145-5p, miR-140-3p), except one (miR-143-3p), were downregulated in the SkM treated group as compared to the untreated group. Furthermore, we found seven genes including Angptl4, Dpep1, Egr1, Eif5a, Tsc22d3, Irs2 and Cebpb that showed a linear correlation with which miRNAs. The downregulation of apoptosis-regulatory miRNAs and in turn upregulation of target genes may partially account for rescue effect of SKM therapy for MI.Keywords
This publication has 36 references indexed in Scilit:
- The Expression Levels of Plasma micoRNAs in Atrial Fibrillation PatientsPLOS ONE, 2012
- MicroRNAs as Biomarkers for Myocardial InfarctionCurrent Atherosclerosis Reports, 2012
- Role of MicroRNAs in Cardiac Remodeling and Heart FailureCardiovascular Drugs and Therapy, 2011
- The Art of MicroRNA ResearchCirculation Research, 2011
- MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart DiseaseCirculation, 2010
- MicroRNA-21 is a key determinant in IL-11/Stat3 anti-apoptotic signalling pathway in preconditioning of skeletal myoblastsCardiovascular Research, 2010
- Altered expression of microRNAs in the myocardium of rats with acute myocardial infarctionBMC Cardiovascular Disorders, 2010
- miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cellsCell Death & Differentiation, 2009
- MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injuryGenes & Development, 2009
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001